Healthcare provider profile · identity verified

Caroline Rogi, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1346771334

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	199
Amlodipine Besylate	Amlodipine Besylate	344	146
Albuterol Sulfate Hfa	Albuterol Sulfate	301	100
Losartan Potassium	Losartan Potassium	246	99
Metoprolol Succinate	Metoprolol Succinate	174	67
Fluticasone Propionate	Fluticasone Propionate	172	74
Gabapentin	Gabapentin	168	71
Lisinopril	Lisinopril	168	66
Furosemide	Furosemide	146	61
Metformin Hcl	Metformin Hcl	139	60
Ibuprofen	Ibuprofen	135	44
Omeprazole	Omeprazole	119	42
Diclofenac Sodium	Diclofenac Sodium	106	63
Prednisone	Prednisone	100	42
Trazodone Hcl	Trazodone Hcl	93	34
Hydrochlorothiazide	Hydrochlorothiazide	90	35
Montelukast Sodium	Montelukast Sodium	87	35
Pantoprazole Sodium	Pantoprazole Sodium	86	48
Rosuvastatin Calcium	Rosuvastatin Calcium	86	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	41
Duloxetine Hcl	Duloxetine Hcl	74	32
Carvedilol	Carvedilol	65	29
Baclofen	Baclofen	63	32
Simvastatin	Simvastatin	62	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	12
Trulicity	Dulaglutide	58	11
Famotidine	Famotidine	57	25
Nifedipine Er	Nifedipine	55	25
Azithromycin	Azithromycin	54	40
Oxybutynin Chloride Er	Oxybutynin Chloride	53	22
Ezetimibe	Ezetimibe	50	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	19
Potassium Chloride	Potassium Chloride	50	18
Tamsulosin Hcl	Tamsulosin Hcl	50	26
Eliquis	Apixaban	49	12
Glipizide	Glipizide	49	26
Tramadol Hcl	Tramadol Hcl	48	16
Metformin Hcl Er	Metformin Hcl	45	11
Allopurinol	Allopurinol	44	16
Spironolactone	Spironolactone	44	17
Pregabalin	Pregabalin	41	16
Levothyroxine Sodium	Levothyroxine Sodium	40	18
Naproxen	Naproxen	38	28
Sertraline Hcl	Sertraline Hcl	38	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	16
Hydrocortisone	Hydrocortisone	37	suppressed
Jardiance	Empagliflozin	37	17
Tizanidine Hcl	Tizanidine Hcl	36	23
Clopidogrel	Clopidogrel Bisulfate	35	17
Clobetasol Propionate	Clobetasol Propionate	33	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	28
Alendronate Sodium	Alendronate Sodium	28	15
Meclizine Hcl	Meclizine Hcl	28	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	12
Mounjaro	Tirzepatide	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	20
Buspirone Hcl	Buspirone Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Doxycycline Monohydrate	Doxycycline Monohydrate	23	21
Linzess	Linaclotide	23	suppressed
Meloxicam	Meloxicam	23	11
Valsartan	Valsartan	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	12
Nitroglycerin	Nitroglycerin	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Lactulose	Lactulose	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	15
Ozempic	Semaglutide	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Colchicine	Colchicine	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Mirtazapine	Mirtazapine	14	11
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	12
Xarelto	Rivaroxaban	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Estradiol	Estradiol	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error